Isovalerate

Isovalerate has been studied in 1 paper since 2025: 1 observational study in people. The newest paper, Nov 1, 2025: “Fecal short-chain fatty acids vary by sex and amyloid status”.

Intervention

1 paper studies it13 more mention it1 findingUpdated

PubChemChEBI

See all 14 papers on isovalerate

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Fecal propionate, isovalerate, and propionate-producing bacteria are inversely associated with amyloid status.”
Fecal short-chain fatty acids vary by sex and amyloid statusAlzheimer's & dementia : the journal of the Alzheimer's Association2025doi:10.1002/alz.70877
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: Alzheimer's Association and others
  • 1 of 1 finding with company ties
  • Humans1

What is isovalerate linked with?

1

Studies link isovalerate with amyloid status.

Amyloid status

downin humans1

1 study
  1. Isovalerate is associated with amyloid status in humans.

    “Fecal propionate, isovalerate, and propionate-producing bacteria are inversely associated with amyloid status.”

    Humansfecesn = 287

    Fecal short-chain fatty acids vary by sex and amyloid status

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Amyloid status

Latest

Dec 2025: 1Jan 2026: 2Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 04 papers in 12 months

See all 14 papers on isovalerate